ELAN
Elanco Animal Health Incorporated
ELAN lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.
ELAN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Healthy | |
| Weak |
ELAN's revenue and cash flow are currently healthy, but its profitability and balance sheet are under pressure.
ELAN PE Valuation
ELAN has no meaningful PE right now: it lost money over the past year.
ELAN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for ELAN, with profitability improving. However, they disagree widely on these estimates.
ELAN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.24 | — |
| Q3 2026 | -$0.29 | -514% |
| Q2 2026 | -$0.40 | -146% |
| Q1 2026 | -$0.49 | -165% |
| Q4 2025 | -$0.47 | -169% |
| Q3 2025 | $0.07 | -83% |
| Q2 2025 | $0.87 | +$3.42 |
| Q1 2025 | $0.75 | +$3.40 |
| Q4 2024 | $0.68 | +$3.18 |
ELAN has swung to a loss: it lost $0.29 per share over the past year, after a profit the year before.
ELAN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.3B | +11% |
| Q2 2026 | $1.4B | +10% |
| Q1 2026 | $1.4B | +15% |
| Q4 2025 | $1.1B | +12% |
| Q3 2025 | $1.1B | +10% |
| Q2 2025 | $1.2B | +4.8% |
| Q1 2025 | $1.2B | -1% |
| Q4 2024 | $1B | -1.4% |
ELAN's revenue has grown year over year for six quarters in a row: $1.3B last quarter, up 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.9% | +6.3 points |
| Q2 2026 | 4.1% | +2.1 points |
| Q1 2026 | 6.3% | +1.3 points |
| Q4 2025 | -23% | -18 points |
| Q3 2025 | -4.4% | -59 points |
| Q2 2025 | 2% | +4.7 points |
| Q1 2025 | 5% | +4 points |
| Q4 2024 | -5% | +7.3 points |
ELAN's operating margin was 1.9% last quarter, up 6.3 points from the same quarter a year ago.
ELAN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $156M | +23% |
| Q2 2026 | $244M | +36% |
| Q1 2026 | -$38M | +$31M |
| Q4 2025 | $46M | -65% |
| Q3 2025 | $127M | +5.8% |
| Q2 2025 | $180M | +8.4% |
| Q1 2025 | -$69M | -$47M |
| Q3 2024 | $120M | -39% |
ELAN generated $408M in free cash flow over the past year, up 11% from the year before.
ELAN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +600K shares |
| 1 year | +2% | +9.7M shares |
| 3 years | +2.8% | +13.8M shares |
| 5 years | +3.9% | +19.2M shares |
| Available history | +37% | +136M shares |
ELAN has 507M diluted shares, up 2% from a year ago.
ELAN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.4x | High |
| Q2 2026 | 6.4x | High |
| Q1 2026 | 7.2x | High |
| Q4 2025 | 7.6x | High |
| Q3 2025 | 5.4x | High |
| Q2 2025 | 2.9x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | 3.4x | Elevated |
ELAN's net debt is about 5.4 years of its operating earnings (EBITDA), about the same as a year ago.
ELAN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 61.4 | Neutral |
| Stochastic | 59.7 | Neutral |
ELAN's weekly RSI is 61 (neutral) and its Stochastic is 60 (neutral).
ELAN PE vs Healthcare Sector
| Metric | ELAN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
ELAN has no meaningful PE right now: it lost money over the past year.
ELAN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $23.6 | 12% above |
| 20 week MA | $24.0 | 11% above |
| 50 week MA | $23.7 | 12% above |
| 100 week MA | $19.2 | 38% above |
| 200 week MA | $16.0 | 65% above |
ELAN is in an uptrend: it's above all five of its weekly moving averages, and 65% above its 200-week average.
ELAN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.3 | $30.5 | +4.1% |
| 2021 | $30.5 | $28.9 | -5.4% |
| 2022 | $28.9 | $11.7 | -59% |
| 2023 | $11.7 | $14.9 | +27% |
| 2024 | $14.9 | $12.1 | -19% |
| 2025 | $12.1 | $22.6 | +87% |
| 2026 YTD | $22.6 | $26.5 | +17% |
ELAN has finished lower in three of the last six years. It's up 17% so far in 2026.